🇺🇸 FDA
Patent

US 8685924

Preventives/remedies for stress urinary incontinence and method of screening the same

granted A61KA61K31/00A61K31/136

Quick answer

US patent 8685924 (Preventives/remedies for stress urinary incontinence and method of screening the same) held by Takeda Pharmaceutical Company Limited expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/00, A61K31/136, A61K31/137, A61K31/165